Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BRD2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCNL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LRRFIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PTMA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TIPIN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TFDP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SDS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTCF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GSR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KIF22 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MELK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CPD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NFIB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HACD3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SMA4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
SRSF4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WAC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TACC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ISG20L2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDC14B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on